Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Prehosp Emerg Care. 2016 Sep 16;21(2):209–215. doi: 10.1080/10903127.2016.1218985

Table 3.

Agreement between EMS vs. ED/hospital providers for preinjury anticoagulant or antiplatelet use

Preinjury medication n (%) per EMS providers Overall agreement, % Positive agreement, % Negative agreement, % Kappa statistic (95% CI)
Warfarin 123 (5.8) 96.9 67.3 99.5 0.76 (0.71–0.82)
DOAC a 7 (0.3) 99.4 33.3 99.9 0.45 (0.19–0.71)
Aspirin 184 (8.7) 84.5 30.6 96.0 0.33 (0.28–0.39)
Other antiplatelet agent b 115 (5.5) 96.1 40.0 99.3 0.51 (0.42–0.60)

Abbreviations: EMS, Emergency Medical Services; ED, emergency department

a

Direct oral anticoagulant, includes dabigatran, rivaroxaban, and apixaban

b

Other antiplatelet agent includes clopidogrel, ticlodipine, prasugrel, dipyridamole, cilostazol, or ticagrelor